A laminated sheet or a container includes: an absorbing layer absorbing at least one of liquid and gas; a reinforcing layer laminated on the absorbing layer with an adhesive layer interposed therebetween; an aluminum layer laminated on the reinforcing layer with an adhesive layer interposed therebetween; and a barrier layer laminated on the aluminum layer with an adhesive layer interposed therebetween and suppressing entry of at least one of liquid and gas.

A substrate comprising a crosslinked polymer primer layer, and grafted thereto a ligand-functionalized polymer is provided. The grafted polymer has the requisite affinity for binding neutral or negatively charged biomaterials, such as cells, cell debris, bacteria, spores, viruses, nucleic acids, and proteins, at pH's near or below the pI's of the biomaterials.

A quantum rod sheet includes: a first support layer including a plurality of grooves which extends substantially in a predetermined direction; a plurality of quantum rods arranged substantially in the predetermined direction along the grooves of the first support layer; and a second support layer which covers the first support layer and the quantum rods.

Aqueous inkjet ink formulations comprising a solvent including water and a co-solvent, a water soluble or water dispersible polymeric resin and a colorant, and a method for facilitating the use of such an aqueous inkjet ink in an indirect printing system in which the ink is jetted onto a hydrophobic release layer of an intermediate transfer member before having the solvent removed therefrom and being transferred to a substrate, wherein prior to the jetting of the ink the release layer is brought into contact with an aqueous solution of a positively charged polymeric chemical agent. Other aspects are also described.

The invention relates in various embodiments to a composite useful as e.g. a medical implant device, and a method of treating fouling, including biofouling as may occur on an implant. The composite comprises a matrix phase and a patterned phase that comprises an energetically activatable wire intermixed with the matrix phase, the wire when energetically activated, which includes thermal activation, causes modification of at least a portion of the matrix phase to treat fouling that might otherwise occur. The method of treating biofouling may be practiced on a patent while the medical implant of the invention is in situ.

Provided is an a aramid-resin film laminate comprising an aramid paper comprising an aramid fibrid and an aramid short fiber, and a resin film laminated on each other. The aramid-resin film laminate is obtained by conducting a plasma treatment on a surface of the aramid paper, the surface having a skin layer portion whose heat of fusion measured with a differential scanning calorimeter (DSC) is 25 cal/g or less, and bonding the aramid paper and the resin film to each other by heating, pressing, or heating under pressure, with the plasma treated surface of the aramid paper and a plasma treated surface of the resin film facing each other. This laminate is an aramid-resin film laminate in which the aramid paper and the resin film are laminated on each other without using any adhesive agent and without impairing characteristics of both the aramid paper and the resin film, and is excellent in heat resistance, electrical characteristics, chemical resistance, mechanical characteristics, and the like.

An adhesive composition including predominantly one or two polyamide(s) having units chosen from: at least one unit denoted A with a mean number of carbon atoms per nitrogen atom, denoted CA, ranging from 4 to 8.5, advantageously from 4 to 7; at least one unit denoted B with a mean number of carbon atoms per nitrogen atom, denoted CB, ranging from 7 to 10, advantageously from 7.5 to 9.5; at least one unit denoted C with a mean number of carbon atoms per nitrogen atom, denoted CC, ranging from 9 to 18, advantageously from 10 to 18, and to the use thereof.

The present invention relates to novel nanocomposite materials, methods of making nanocomposites and uses of nanocomposite materials.

The present invention thermoplastic polymer composition, an article prepared form the thermoplastic polymer composition, and article made by a LDS process and a process for preparing the same, wherein the thermoplastic polymer 5 composition N comprises a thermoplastic polymer comprising a thermoplastic polyamide or a thermoplastic polyester, a Laser Direct Structuring (LDS) additive, an impact modifier, optionally a reinforcing agent, and a halogen free flame retardant comprising a melamine condensation product, a salt of a polyphosphate and melamine or a melamine condensation product, or a salt of an organic phosphinic acid or diphosphinic 10 acid and a metal, melamine or a melamine condensation product, or any mixture thereof.

A substrate comprising a crosslinked polymer primer layer, and grafted thereto a ligand-functionalized polymer is provided. The grafted polymer has the requisite affinity for binding neutral or negatively charged biomaterials, such as cells, cell debris, bacteria, spores, viruses, nucleic acids, and proteins, at pH's near or below the pI's of the biomaterials.